Iktos is a French start-up company which develops a truly innovative and disruptive artificial intelligence technology for ligand-based de novo drug design, focusing on MPO (multi parametric optimization).
Our innovative algorithm is based on state of the art deep learning models, called generative models, and enables to design new, druggable and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance.
No products posted yet
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality